You are here: vision-research.eu » News

News

Outcomes worse for immediate sequential bilateral cataract surgery

Immediate sequential bilateral cataract surgery (ISBCS) is associated with worse visual outcomes compared with short-interval (one to 14 days between operations) delayed sequential bilateral cataract surgery (DSBCS-14) and long-interval (15 to 90 days) DSBCS (DSBCS-90), according to a study published in JAMA Ophthalmology.

Automated direct SLT demonstrates safety, efficacy in first human trial

Automated direct selective laser trabeculoplasty appears to reduce IOP in patients with primary open-angle glaucoma, according to a speaker here.

New glaucoma test 15 times more likely to detect high risk patients

The latest investigations into a promising new genetic test for glaucoma—the leading cause of blindness worldwide—has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test.

Mobile screening app triples eye care uptake

Using smartphones for eye screening and referrals could triple the number of people seeking primary care for eye problems and increase the uptake of hospital services in low-resource settings, a study says.

How a holistic research retreat can help our science

After an existential crisis, we realized we needed to think more deeply about our careers

IOTA study: One donor cornea may help treat ‘hundreds of patients’

Instead of using one donor cornea for one patient, endothelial cell therapy may allow tissue from one donor to be used by as many as 100 patients, according to a study.

European Research and Innovation Days 2021:

We need EU research and innovation to ensure a sustainable Europe

Cross-linking may provide alternative treatment for early infectious keratitis

Cross-linking may have a role as an alternative to antimicrobial therapy for early infectious keratitis, according to research presented at the American Society of Cataract and Refractive Surgery meeting.

Researchers: HtrA1 augmentation is potential therapy for age-related macular degeneration

Research conducted at the Sharon Eccles Steele Center for Translational Medicine (SCTM) at the University of Utah's John A. Moran Eye Center explains why people carrying a block of genetic variants strongly associated with the development of age-related macular degeneration (AMD) may develop the disease and identifies a potential therapeutic pathway for slowing or even reversing disease progression.

Three Deputy Director roles re-appointed at the IoO in London

We’re delight to hear of some re-appointments at the IoO.

This is how the visual system shows us a more persistent world

Imagine meeting a friend on the street, and imagine that with every step they take, your visual system has to process their image from scratch in order to recognize them. Now imagine if the same thing were to happen for every object and creature that moves around us. We would live in a constant state of uncertainty and inconsistency. Luckily, that is not the case.

Commission launch one-stop-shops for EU-Africa cooperation in research and innovation

The European Commission today launched two new platforms, the EU-Africa (EU-AU) cooperation in research and innovation (R&I) portal and the EU-Mediterranean cooperation in R&I portal to provide one-stop-shops for all policy-makers and stakeholders interested in EU-Africa cooperation on research and innovation.

Vision impairment tied to cognitive decline

Worse visual acuity, contrast sensitivity, and stereo acuity impairment are associated with an increased risk for cognitive decline in older, community-dwelling individuals, according to a study published in JAMA Network Open.

New biomarkers in the eyes could unlock the key to management of diabetic retinopathy

New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according to new research conducted at the Indiana University School of Optometry.

Atropine plus patching increases visual acuity in amblyopic eyes

For children with severe amblyopia, combined atropine and patching therapy (CAPT) results in greater mean improvement of amblyopic eye visual acuity (VA) compared with patching alone, according to a study published in JAMA Ophthalmology.